Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement. - Usefulness of combined femoral nerve blockade and tibital nerve block in patients undergoing bilateral knee replacement.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009141

Enrollment

100

Registered

2013-01-01

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Being prepared.

Interventions

Femoral nerve blockade with 0.25% levobupivacaine. Femoral nerve blockade with 0.125% levobupivacaine.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA physical status classification I or II.

Exclusion criteria

Exclusion criteria: Central or peripheral nerve dysfunction.

Design outcomes

Primary

Measure	Time frame
Femoral nerve block with different concentrations will cause the same analgesic effect.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026